Melissa Reagen is leaving Aberdeen Asset Management to join the research and valuations team at MetLife’s new and growing real estate division.
Next month, Reagen will become the associate director of research and valuation at MetLife Real Estate Investors. Starting July 8, she will work out of the Morristown, New Jersey headquarters office and report directly to Richard McLemore, director of research and portfolio risk at MetLife Real Estate. “I am really looking forward to this new chapter,” Reagen told PERE via email.
In October, MetLife announced that it was looking to expand into the third-party asset management business after managing assets solely for its own account. Since then, the US life insurance giant has been building its asset management business for outside investors, focusing on investments in real estate equity, commercial mortgages and private debt. The real estate group, which was renamed MetLife Real Estate Investors, currently manages about $42 billion of commercial mortgages and $12 billion in direct real estate investments.
Reagen joined Aberdeen as head of property research for the Americas in 2011 and was responsible for researching real estate data across the region. Prior to joining Aberdeen, she worked at LaSalle Investment Management, where her research and strategy responsibilities included being the lead strategist on the firm's US multifamily portfolio and providing multi-sector advice to the $2 billion LaSalle US Property Fund.